141 related articles for article (PubMed ID: 29251024)
1. Outcome of transition phase patients with juvenile idiopathic arthritis.
Relas H; Luosujärvi R; Kosola S
Mod Rheumatol; 2018 Sep; 28(5):832-837. PubMed ID: 29251024
[TBL] [Abstract][Full Text] [Related]
2. Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease.
Relas H; Kosola S
Clin Rheumatol; 2019 Mar; 38(3):785-791. PubMed ID: 30374749
[TBL] [Abstract][Full Text] [Related]
3. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
Luque Ramos A; Hoffmann F; Albrecht K; Klotsche J; Zink A; Minden K
Semin Arthritis Rheum; 2017 Oct; 47(2):269-275. PubMed ID: 28583690
[TBL] [Abstract][Full Text] [Related]
4. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies.
Vidqvist KL; Malin M; Varjolahti-Lehtinen T; Korpela MM
Rheumatology (Oxford); 2013 Nov; 52(11):1999-2003. PubMed ID: 23893666
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan.
Miyamae T; Tanaka E; Kishi T; Matsuyama T; Igarashi T; Fujikawa S; Taniguchi A; Momohara S; Yamanaka H
Mod Rheumatol; 2015 Jan; 25(1):62-6. PubMed ID: 25019624
[TBL] [Abstract][Full Text] [Related]
6. Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.
Lee WJ; Briars L; Lee TA; Calip GS; Suda KJ; Schumock GT
Pharmacotherapy; 2016 Dec; 36(12):1201-1209. PubMed ID: 27779782
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].
Niewerth M; Minden K; Klotsche J; Horneff G
Z Rheumatol; 2014 Aug; 73(6):532-40. PubMed ID: 25096586
[TBL] [Abstract][Full Text] [Related]
8. Disease activity and dropout in young persons with juvenile idiopathic arthritis in transition of care: a longitudinal observational study.
van Pelt PA; Dolhain RJEM; Kruize AA; Ammerlaan JJW; Hazes JW; Bijlsma JWJ; Wulffraat NM
Clin Exp Rheumatol; 2018; 36(1):163-168. PubMed ID: 29461957
[TBL] [Abstract][Full Text] [Related]
9. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
[TBL] [Abstract][Full Text] [Related]
10. Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments.
Marino A; Stagi S; Simonini G; Carli N; Caparello MC; Giani T; Pagnini I; De Masi S; Cimaz R
Clin Exp Rheumatol; 2018; 36(5):929-933. PubMed ID: 30148444
[TBL] [Abstract][Full Text] [Related]
11. The importance of transition from pediatric to adult rheumatology care in juvenile idiopathic arthritis.
de Oliveira RJ; Kishimoto ST; de Souza DP; Fernandes PT; Marini R; Appenzeller S
Expert Rev Clin Immunol; 2021 Feb; 17(2):155-161. PubMed ID: 33393405
[No Abstract] [Full Text] [Related]
12. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
[TBL] [Abstract][Full Text] [Related]
13. New Medications Are Needed for Children With Juvenile Idiopathic Arthritis.
Brunner HI; Schanberg LE; Kimura Y; Dennos A; Co DO; Colbert RA; Fuhlbrigge RC; Goldmuntz E; Kingsbury DJ; Patty-Resk C; Mintz S; Onel K; Rider LG; Schneider R; Watts A; von Scheven E; Lovell DJ; Beukelman T;
Arthritis Rheumatol; 2020 Nov; 72(11):1945-1951. PubMed ID: 32524767
[TBL] [Abstract][Full Text] [Related]
14. Later-onset rheumatoid factor negative polyarticular juvenile idiopathic arthritis (JIA): a unique patient group?
Greenwald AG; Zakerzadeh A; Laxer RM; Schneider R; Cameron B; Feldman B; Spiegel L; Tse SM; Silverman ED
Clin Exp Rheumatol; 2013; 31(4):645-52. PubMed ID: 23622111
[TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use.
Aalto K; Lahdenne P; Kolho KL
Pediatr Rheumatol Online J; 2017 Jan; 15(1):9. PubMed ID: 28143478
[TBL] [Abstract][Full Text] [Related]
16. Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients.
Romano M; Pontikaki I; Gattinara M; Ardoino I; Donati C; Boracchi P; Meroni PL; Gerloni V
Reumatismo; 2014 Mar; 65(6):278-85. PubMed ID: 24705031
[TBL] [Abstract][Full Text] [Related]
17. Use and perceived relevance of health-related Internet sites and online contact with peers among young people with juvenile idiopathic arthritis.
van Pelt PA; Drossaert CH; Kruize AA; Huisman J; Dolhain RJ; Wulffraat NM
Rheumatology (Oxford); 2015 Oct; 54(10):1833-41. PubMed ID: 25998449
[TBL] [Abstract][Full Text] [Related]
18. Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience.
Scagnellato L; Cozzi G; Prosepe I; Lorenzin M; Doria A; Martini G; Zulian F; Ramonda R
PLoS One; 2024; 19(5):e0298679. PubMed ID: 38696444
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.
Semalulu T; Berard R; Beattie K; Basodan D; Boire G; Bolaria R; Cabral D; Chhabra A; Gerschman T; Johnson N; Herrington J; Houghton K; Lim L; Miettunen PMH; Park J; Proulx-Gauthier JP; Schmeling H; Scuccimarri R; Tam H; Tucker L; Guzman J; Batthish M;
J Rheumatol; 2024 Apr; 51(4):403-407. PubMed ID: 38302168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
